PA

Padmanabhan Ananthanarayanan Palamadai

Active Director Nominee Director DIN 06901013
DIN 06901013 First appointment Jul 2004 Primary industry Information Technology
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 6 historical roles
Total affiliations 7 Since Jul 2004
Shareholding value •••• Premium profile

About Padmanabhan Ananthanarayanan Palamadai

Data last updated:

Padmanabhan Ananthanarayanan Palamadai is a Nominee Director at Etrans Solutions Private Limited (since 2023). The companies operate in Information Technology, Chemicals and Pharma. Etrans Solutions Private Limited reported revenue of ₹38.02 Cr (FY 2026). Earlier, Padmanabhan Ananthanarayanan Palamadai was a Nominee Director at Etrans T4u Private Limited (2020–2023) and Director at German Remedies Healthcare Private Limited (2014–2018) and 4 more.

DIN 06901013
Primary Designation Nominee Director
Industry Information Technology
First Appointment 27 Jul 2004
Oldest Company Age 26 yrs
Largest company Etrans Solutions Private Limited · ₹38.02 Cr (FY 2026)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Etrans Solutions Private Limited U63090WB2000PTC092223
Nominee Director27 Oct 20232000₹38.02 Cr (FY 2026)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Etrans T4u Private Limited U72900WB2009PTC270989
Nominee Director16 Jun 20202009₹5.85 Cr (FY 2024)Amalgamated
Director18 Jun 20142010Active
Dialforhealth Unity Limited U51390GJ2005PLC046314
Director18 Jun 20142005₹31,000 (FY 2024)Active
Dialforhealth India Limited U85110GJ2000PLC037488
Company Secretary27 Jul 20042000₹4.07 Cr (FY 2019)Amalgamated
Zydus Healthcare Limited U51900GJ1989PLC079501
Cfo01 Dec 20141989₹3,542 Cr (FY 2022)Active
Director10 May 20182018₹334 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Etrans Solutions Private Limited
Etrans T4u Private Limited
German Remedies Healthcare Private Limited
Dialforhealth Unity Limited
Premium access

Shareholding and investment profile for Padmanabhan Ananthanarayanan Palamadai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Padmanabhan Ananthanarayanan Palamadai

Padmanabhan Ananthanarayanan Palamadai currently holds 1 directorship: Etrans Solutions Private Limited (Nominee Director, since 27 Oct 2023, revenue ₹38.02 Cr (FY 2026)).

Padmanabhan Ananthanarayanan Palamadai was first appointed on 27 Jul 2004 as Company Secretary at Dialforhealth India Limited. The most recent appointment on record is 27 Oct 2023 at Etrans Solutions Private Limited.

Padmanabhan Ananthanarayanan Palamadai held 6 earlier board appointments: Etrans T4u Private Limited (Nominee Director, 16 Jun 2020 to 27 Jul 2023); German Remedies Healthcare Private Limited (Director, 18 Jun 2014 to 15 Sep 2018); Dialforhealth Unity Limited (Director, 18 Jun 2014 to 12 Sep 2018); Dialforhealth India Limited (Company Secretary, 27 Jul 2004 to 01 Jan 2014); Zydus Healthcare Limited (Cfo, 01 Dec 2014 to 09 Aug 2018); and 1 more.

The current boards of Padmanabhan Ananthanarayanan Palamadai's companies include Ateesh Tankha (Etrans Solutions Private Limited), Biplab Majumder (Etrans Solutions Private Limited), Dibyendu Bose (Etrans Solutions Private Limited), Paramita Acharya (Etrans Solutions Private Limited), Soumya Kanti Acharya (Etrans Solutions Private Limited), Srikumar Menon (Etrans Solutions Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available